Good to see we getting Finance News coverage
http://www.finnewsnetwork.com.au/CompanyReports/Imugene-Limited/Imugene-Announces-PD|||1-Cancer-Vaccine-Development-Update
Imugene Announces PD-1 Cancer Vaccine Development Update
23 Jul 2018 10:13 AM
• New PD-1 cancer vaccine named KEY-Vaxx
• Phase 1 planning well advanced
• Preclinical results in validated models of colorectal (colon) cancer
demonstrate inhibitory cancer growth activity
MELBOURNE Australia 23 July 2018: Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company is pleased to announce a development update of its newly acquired PD-1 cancer vaccine from Ohio State University. The check-point inhibitor cancer vaccine named KEY-Vaxx, demonstrates superior cancer growth inhibition compared with an industry-standard monoclonal antibody in validated models of colorectal (colon) cancer (CT26).
- Forums
- ASX - By Stock
- IMU
- Ann: PD-1 cancer vaccine development update
Ann: PD-1 cancer vaccine development update, page-43
-
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
-0.001(0.89%) |
Mkt cap ! $416.4M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.5¢ | $488.2K | 8.786M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 3702332 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 1271878 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 4065968 | 0.055 |
26 | 4411458 | 0.054 |
21 | 3789529 | 0.053 |
34 | 5608840 | 0.052 |
34 | 3801154 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 1217016 | 17 |
0.057 | 998890 | 11 |
0.058 | 953278 | 6 |
0.059 | 1117060 | 7 |
0.060 | 800948 | 7 |
Last trade - 11.29am 06/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |